Published in Am J Clin Oncol on April 01, 2007
Rechallenging with anthracyclines and taxanes in metastatic breast cancer. Nat Rev Clin Oncol (2010) 0.86
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study. J Exp Clin Cancer Res (2011) 0.83
Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study. BMC Cancer (2010) 0.80
New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin. Breast Cancer (Dove Med Press) (2009) 0.75
A prospective, assessor-blind evaluation of surgeon-performed transcutaneous laryngeal ultrasonography in vocal cord examination before and after thyroidectomy. Surgery (2013) 1.94
The role of intraoperative neuromonitoring of recurrent laryngeal nerve during thyroidectomy: a comparative study on 1000 nerves at risk. Surgery (2006) 1.55
Changing trend in surgical indication and management for Graves' disease. Am J Surg (2011) 1.06
Graves' ophthalmopathy as an indication increased the risk of hypoparathyroidism after bilateral thyroidectomy. World J Surg (2011) 1.04
Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer. J Steroid Biochem Mol Biol (2008) 1.03
Papillary microcarcinoma: is there any difference between clinically overt and occult tumors? World J Surg (2006) 0.99
Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation? Ann Surg Oncol (2012) 0.95
The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies. J Oncol (2011) 0.88
Clinicopathologic predictors for early and late biochemical hypothyroidism after hemithyroidectomy. Am J Surg (2011) 0.84
Assessing the Validity of Transcutaneous Laryngeal Ultrasonography (TLUSG) After Thyroidectomy: What Factors Matter? Ann Surg Oncol (2014) 0.84
New molecular targeted therapy and redifferentiation therapy for radioiodine-refractory advanced papillary thyroid carcinoma: literature review. J Thyroid Res (2012) 0.84
Can we replace the microscope with microarrays for diagnosis, prognosis and treatment of early breast cancer? Expert Opin Ther Targets (2012) 0.83
Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer. Cancer Lett (2008) 0.81
Use of radiofrequency ablation in benign thyroid nodules: a literature review and updates. Int J Endocrinol (2013) 0.81
Revisiting robotic approaches to endocrine neoplasia: do the data support their continued use? Curr Opin Oncol (2016) 0.80
High pre-operative urinary norepinephrine is an independent determinant of peri-operative hemodynamic instability in unilateral pheochromocytoma/paraganglioma removal. World J Surg (2014) 0.80
The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma. Surgery (2008) 0.79
Is vocal cord asymmetry seen on transcutaneous laryngeal ultrasonography a significant predictor of voice quality changes after thyroidectomy? World J Surg (2014) 0.78
Thyroid surgery for elderly patients: are they at increased operative risks? J Thyroid Res (2012) 0.78
Incidental thyroid carcinoma by FDG-PET/CT: a study of clinicopathological characteristics. Ann Surg Oncol (2010) 0.78
A cost-utility analysis for prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma. Ann Surg Oncol (2013) 0.77
Parathyroid carcinoma in a 30-year-old man: a diagnostic and management challenge. World J Surg Oncol (2013) 0.75
Endoscopic vs robotic thyroidectomy: which is better? Ann Surg Oncol (2011) 0.75